YOLFTbeta
RO

Instituto Rosenbusch S.A.

ROSE · BA · Healthcare / Drug Manufacturers - Specialty & Generic

133.50ARS-0.50 (-0.37%)

Price History

Full chart

Market Stats

Previous Close134.00
Open135.00
Day Range131.00 – 139.50
52-Week Range116.00 – 357.00
Volume4.60K
Market Cap5.98B
P/E (TTM)0.67
Forward P/E0.00
EPS209.72
Dividend Yield0.00%
Beta0.01
50-Day Avg155.71
200-Day Avg177.47

About

Instituto Rosenbusch S.A. manufactures and sells veterinary products in Argentina. The company offers biological products, including products for reproductive-respiratory complex, IBR, BVD, brucelosis, carbuncle, and other diseases; clostridial vaccines; vaccines for cattle, sheep, goats, horses, and dogs; and products for the prevention of pneumonia and calve diarrhea, and cattle infectious keratoconjunctivitis. It also provides pharmaceutical products, such as external and internal antiparasitics, endectocides, antimicotics-bacteriostatics, injectable antibiotics, antimastitics, and other chemotherapics, as well as vitamins and minerals. The company was founded in 1917 and is based in Buenos Aires, Argentina.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEODr. Rodolfo Martín Balestrini
  • Employees0
  • HeadquartersHipólito Yrigoyen 1628 (C1089AAF), Buenos Aires, Argentina, 1136, Argentina
  • Websitehttps://www.rosenbusch.com

Leadership

  • Dr. Rodolfo Martín BalestriniChairman of the Board of Directors & President
  • Oscar EcheverriaFinancial Manager

Financials

Income Statement

Currency: ARS2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue8.17M8.81M24.13M30.36M43.58M54.30M67.05M75.36M53.09M58.98M56.88M71.95M82.86M85.19M107.66M135.49M167.31M172.14M298.92M411.82M558.63M781.61M1.37B9.86B10.89B6.40B
Growth (%)-+7.82%+173.77%+25.83%+43.58%+24.58%+23.48%+12.39%-29.55%+11.08%-3.56%+26.50%+15.16%+2.80%+26.39%+25.85%+23.48%+2.89%+73.65%+37.77%+35.65%+39.92%+75.67%+618.14%+10.40%-41.17%
Cost of Revenue3.96M4.53M11.71M16.83M27.40M39.62M48.82M56.75M38.27M43.30M35.23M42.17M50.63M54.06M70.25M98.50M106.58M114.87M218.11M276.95M370.22M559.18M731.13M6.95B5.84B7.00B
Gross Profit---------------36.99M60.72M57.27M80.81M134.86M188.41M222.42M641.93M2.91B5.04B-598.81M
Gross Margin---------------27.30%36.29%33.27%27.03%32.75%33.73%28.46%46.75%29.49%46.31%-9.35%
Operating Expense---------------38.84M48.34M56.72M79.81M113.82M137.73M214.17M355.75M2.76B2.48B2.54B
Operating Income1.64M1.07M6.75M6.18M3.80M6.57M7.56M2.86M--3.42M10.97M6.67M4.14M2.85M-1.85M12.38M549.91K1.00M21.04M50.68M8.25M286.18M145.94M2.56B-3.14B
Operating Margin20.12%12.13%27.99%20.37%8.73%12.10%11.27%3.79%--6.01%15.25%8.05%4.86%2.65%-1.37%7.40%0.32%0.34%5.11%9.07%1.06%20.84%1.48%23.54%-49.08%
EBITDA-----------------11.40M41.31M-50.46M53.71M47.46M235.28M2.48B-1.02B-2.65B
EBITDA Margin-----------------6.62%13.82%-12.25%9.61%6.07%17.14%25.11%-9.41%-41.37%
Net Income1.00M613.00K-3.54M2.52M4.16M4.10M1.78M-982.00K2.95M5.76M9.28M-8.35M-727.46K10.16M-72.31K798.26K-89.20M-17.01M-19.57M-8.10M1.23B-1.86B-4.60B
Net Income Margin12.27%6.96%-11.66%5.79%7.66%6.12%2.36%-1.67%5.19%8.00%11.20%-7.75%-0.54%6.07%-0.04%0.27%-21.66%-3.04%-2.50%-0.59%12.43%-17.13%-71.80%
Interest Expense00000000000000000015.41M17.13M32.55M34.61M168.45M1.06B822.99M1.65B
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%5.15%4.16%5.83%4.43%12.27%10.73%7.56%25.78%

Balance Sheet

Currency: ARS2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets14.71M15.34M29.55M35.60M39.12M45.57M48.52M53.83M57.44M64.48M73.42M86.92M114.90M125.89M140.75M166.17M197.86M213.52M366.76M496.94M675.64M747.29M1.35B10.98B9.92B7.75B
Total Liabilities2.81M2.75M5.39M7.33M8.71M11.43M12.55M16.33M11.80M17.54M23.23M30.68M49.02M68.24M72.51M95.55M114.62M126.95M220.81M381.42M527.95M548.10M947.48M6.43B5.93B8.27B
Total Equity11.90M12.59M24.17M28.27M30.41M34.13M35.97M37.12M45.05M46.03M48.99M54.49M63.86M54.82M64.02M64.63M75.75M77.11M127.72M104.82M130.14M177.02M362.80M4.17B3.74B-800.17M
Cash206.00K373.00K2.04M--3.60M918.00K-5.32M1.99M3.02M4.94M6.89M2.31M5.08M7.55M6.17M5.35M14.93M15.76M47.90M56.96M106.60M850.98M1.15B712.26M
Net Debt-----------------37.92M78.91M109.31M107.22M134.02M238.34M1.40B1.14B737.74M

Cash Flow

Currency: ARS2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow248.00K-1.85M4.82M-5.24M2.12M753.00K8.36M1.06M5.11M11.23M--9.21M-8.83M15.84M-3.51M-22.06M59.20M65.78M58.37M49.25M331.37M720.31M409.89M
Investing Cash Flow-------------812.00K--2.45M-15.75M-3.01M-1.51M-9.81M-2.99M-4.18M-26.54M---
Financing Cash Flow115.00K---687.00K--2.36M-385.00K-573.00K20.35M1.95M-13.75M-1.46M3.06M30.60M-59.21M-22.86M-84.10M-27.07M---
Capital Expenditure92.00K271.00K388.00K1.07M2.56M2.62M3.25M1.25M2.74M4.77M3.78M9.81M04.21M4.17M2.42M15.76M3.01M1.51M9.84M2.99M4.18M26.54M115.45M13.65M12.13M
Free Cash Flow------------------10.99M-23.57M12.05M41.60M27.82M22.72M215.92M706.67M397.75M
Dividends Paid----166.00K400.00K2.22M700.00K--------24.21M32.96M32.96M32.96M------
FCF to OCF-----------------312.83%106.83%20.36%63.24%47.66%46.12%65.16%98.11%97.04%
Dividend Paid to FCF------------------299.99%-139.87%273.50%------

Earnings

Report DateJun 30, 2009Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Jun 30, 2016Sep 30, 2016Dec 31, 2016Mar 31, 2017Jun 30, 2017Sep 30, 2017Dec 31, 2017Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Dec 31, 2019Mar 31, 2020May 21, 2021Mar 28, 2022May 13, 2022Aug 12, 2022Nov 15, 2022Dec 31, 2022
EPS Estimate-----------------------------------
EPS Actual0.040.07-0.03-0.04-0.05-0.080.27-0.140.14-0.08-0.01-0.08-0.070.140.030.04-0.010.180.050.05-0.02-0.08-0.050.080.48-1.18-0.11-1.01-0.00-0.150.140.640.09-0.49-0.82
Surprise-----------------------------------
Timing------------------------------Pre-marketPre-marketPre-marketPre-market-

Key Statistics & Ratios

Market Cap5.98B
Enterprise Value8.66B
Trailing P/E0.67
Forward P/E0.00
Price / Sales0.88
Price / Book0.86
EPS209.72
Book Value-18.79
Revenue (TTM)6.81B
Gross Profit (TTM)180.66M
EBITDA-3.18B
Profit Margin2.69%
Operating Margin-26.98%
Return on Equity5.54%
Return on Assets-13.75%
Shares Outstanding42.58M
Shares Float8.50M
Beta0.01
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20071×
0.02May 18, 2007
20061×
0.06May 22, 2006
20051×
0.01May 19, 2005
20041×
0.00May 26, 2004

Stock Splits

  • Nov 16, 2011596:415
  • Nov 21, 20076:5
  • Aug 5, 20041125:512
  • Aug 13, 20011171:1032